SR 33287
Latest Information Update: 28 Jul 1994
Price :
$50 *
At a glance
- Originator Sanofi Winthrop
- Class Antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias